| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0002-9149(00)01293-5 |
| P698 | PubMed publication ID | 11084102 |
| P2093 | author name string | Cannom DS | |
| P2860 | cites work | Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology | Q29547464 |
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators | Q33144638 | ||
| Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone | Q33145337 | ||
| Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study | Q33145900 | ||
| Mortality in patients with implanted automatic defibrillators | Q71724114 | ||
| Unsustained ventricular tachycardia--to treat or not to treat | Q71875529 | ||
| Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease | Q72284964 | ||
| Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group | Q72467999 | ||
| Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control | Q72637569 | ||
| A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators | Q72833438 | ||
| Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest | Q72885810 | ||
| Sudden death in high-risk family members: Brugada syndrome | Q73204523 | ||
| A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators | Q73280436 | ||
| Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design | Q74630665 | ||
| Estimating the proportion of post-myocardial infarction patients who may benefit from prophylactic implantable defibrillator placement from analysis of the CAST registry. Cardiac Arrhythmia Suppression Trial | Q77225781 | ||
| The value of cardiovascular autonomic function tests: 10 years experience in diabetes | Q93631227 | ||
| A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias | Q33175452 | ||
| Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease | Q33175526 | ||
| QT dispersion: an indication of arrhythmia risk in patients with long QT intervals | Q33610985 | ||
| Screening and therapy for patients with nonsustained ventricular tachycardia | Q34085395 | ||
| Decreased heart rate variability and its association with increased mortality after acute myocardial infarction | Q34191387 | ||
| Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy | Q34467569 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 | ||
| Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). | Q34682919 | ||
| A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group | Q34718800 | ||
| Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias | Q38186779 | ||
| Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College | Q39254363 | ||
| Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction | Q39362936 | ||
| Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias | Q39430818 | ||
| Ventricular Premature Beats and Mortality after Myocardial Infarction | Q39450946 | ||
| Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest | Q42548363 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators | Q44086151 | ||
| Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction | Q44442368 | ||
| Long-term outcome with the automatic implantable cardioverter-defibrillator. | Q45996829 | ||
| Management of ventricular arrhythmias: detection, drugs, and devices. | Q46004263 | ||
| Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. | Q50584108 | ||
| Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. | Q52482358 | ||
| Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens | Q52704369 | ||
| Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control | Q52866496 | ||
| Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up. | Q54191149 | ||
| Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trial | Q56271168 | ||
| Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy | Q58819293 | ||
| Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction | Q66940532 | ||
| A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia | Q68214149 | ||
| Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome | Q68251667 | ||
| Implantable defibrillation: eight years clinical experience | Q69051118 | ||
| Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia | Q69062277 | ||
| A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring | Q69062283 | ||
| Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography | Q69754268 | ||
| Effect of propranolol after acute myocardial infarction in patients with congestive heart failure | Q70014101 | ||
| A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results | Q70220432 | ||
| Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction | Q70489209 | ||
| Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease | Q70541271 | ||
| Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease | Q70678043 | ||
| Prognosis after myocardial infarction | Q71057193 | ||
| Prognostic significance of late ventricular potentials after acute myocardial infarction | Q71066360 | ||
| A perspective on the ESVEM trial and current knowledge: catheter ablation for ventricular tachyarrhythmias | Q71095739 | ||
| P433 | issue | 9A | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | defibrillator | Q1450682 |
| P304 | page(s) | 58K-70K | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Matching cardiac rhythm management technology to patient needs: pacing/ablation/implantable cardioverter defibrillators | |
| P478 | volume | 86 |
Search more.